Multiple inflammatory mechanisms in eosinophilic oesophagitis make it unlikely that single pathway inhibition by monoclonal biological therapies would succeed-Reference-Cited by-同舟云学术

Multiple inflammatory mechanisms in eosinophilic oesophagitis make it unlikely that single pathway inhibition by monoclonal biological therapies would succeed

Published:2023-08-27 Issue:10 Volume:72 Page:1806-1807
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Attwood Stephen E^ORCID

Publisher

BMJ

Subject

Gastroenterology

Reference10 articles.

1. Hahn JW , Lee K , Shin JI , et al . Global incidence and prevalence of eosinophilic esophagitis, 1976-2022: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2023. doi:10.1016/j.cgh.2023.06.005

2. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults

3. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the eoe connect registry;Laserna-Mendieta;Aliment Pharmacol Ther,2020

4. Histologic and clinical effects of different topical corticosteroids for eosinophilic esophagitis: lessons from an updated meta-analysis of placebo-controlled randomized trials;de Heer;Digestion,2021

5. Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial;Lucendo;Gastroenterology,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis;New England Journal of Medicine;2024-06-27

2. Eosinophilic oesophagitis: practical management and novel therapeutics;Medicine;2024-03